Pedro Besada Pereira

Title: Pedro Besada Pereira: Innovator in Pharmacological Treatments

Introduction

Pedro Besada Pereira is a notable inventor based in Vigo, Spain. He has made significant contributions to the field of pharmacology, particularly in the treatment of lysosomal storage diseases and neurodegenerative disorders. With a total of two patents to his name, his work has the potential to impact many lives.

Latest Patents

One of his latest patents is focused on the use of pharmacological chaperones for the treatment of lysosomal storage diseases. This invention relates to the use of galactose analogues that stabilize the structure of the α-GalA enzyme, specifically for treating Fabry disease. Additionally, he has developed pharmacological compositions containing these galactose analogues for effective treatment.

Another significant patent involves pyridazin-3(2H)-one derivatives as selective inhibitors of monoamine oxidase isoform B. This invention targets disorders resulting from MAO-B hyperactivity, including Parkinson's disease and Alzheimer's disease. The derivatives are designed with dithiocarbamate moieties, enhancing their therapeutic potential.

Career Highlights

Pedro has worked at esteemed institutions such as the University of Vigo and the University of Santiago de Compostela. His academic background and research have laid the foundation for his innovative patents and contributions to pharmacology.

Collaborations

Throughout his career, Pedro has collaborated with notable colleagues, including Ma Del Carmen Terán Moldes and Tamara Costas Caamaño. These partnerships have enriched his research and development efforts.

Conclusion

Pedro Besada Pereira is a distinguished inventor whose work in pharmacological treatments showcases his commitment to advancing medical science. His patents reflect a deep understanding of complex diseases and a dedication to improving patient outcomes.